A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...
The cancer diagnostics market was valued at $168,600.04 million in 2020, and is projected to reach $280,590.21 million by 2028, registering a CAGR of 6.9% from 2021 to 2028. The major factor that ...